Effectiveness of bortezomib in multiple myeloma: Preliminary results from an international electronic observational study

被引：0
|
作者：
Delforge, M. [1 ]
Katodritou, E. [2 ]
Zervas, K. [2 ]
Sargin, D. [3 ]
Hulin, C. [4 ]
Linderholm, M. [5 ]
Verrou, E. [2 ]
Poon, V [6 ]
Dhawan, R. [6 ]
机构：
[1] Katholieke Univ Leuven Hosp, Louvain, Belgium
[2] Theagenion Canc Ctr, Thessaloniki, Greece
[3] Istanbul Univ, Istanbul, Turkey
[4] CHU NANCY Brabois, Nancy, France
[5] Linkoping Univ Hosp, S-58185 Linkoping, Sweden
[6] Johnson & Johnson Pharmaceut Serv, Raritan, NJ USA
来源：
VALUE IN HEALTH | 2008年 / 11卷 / 03期
关键词：
D O I：
10.1016/S1098-3015(10)70183-2
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A55 / A55
页数：1
相关论文
共 50 条
  • [1] PRELIMINARY RESULTS FROM AN ELECTRONIC OBSERVATIONAL STUDY ON BORTEZOMIB'S EFFECTIVENESS IN ADVANCED MULTIPLE MYELOMA
    Dimopoulos, M. A.
    Roussou, M.
    Katodritou, E.
    Zervas, K.
    Delforge, M.
    Linderholm, M.
    Sargin, D.
    Hulin, C.
    Poon, V.
    Dhawan, R.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 527 - 527
  • [2] Response to bortezomib therapy for multiple myeloma (MM) in actual clinical practice: Preliminary effectiveness findings of an international observational study
    Delforge, Michel
    Katodritou, Eirini
    Zervas, Konstantinos
    Sargin, Deniz
    Hulin, Cyrille
    Linderholm, Mats
    Verrou, Evgenia
    Poon, Vicki
    Dhawan, Ravinder
    BLOOD, 2007, 110 (11) : 284B - 284B
  • [3] Bortezomib International Observational Study in Multiple Myeloma: Baseline Characteristics
    Zervas, K.
    Dhawan, R.
    Delforge, M.
    Samblanx, H.
    Sargin, D.
    Hulin, C.
    Linderholm, M.
    De la Rubia, J.
    Abdulkadyrov, K.
    Ganguly, R.
    Diels, J.
    CLINICAL LYMPHOMA & MYELOMA, 2009, 9 : S22 - S22
  • [4] SURVIVAL ANALYSIS OF PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA: AN INTERIM REPORT FROM AN INTERNATIONAL ELECTRONIC OBSERVATIONAL STUDY OF BORTEZOMIB
    Delforge, M.
    de Samblanx, H.
    Zervas, K.
    Katodritou, E.
    Sargin, D.
    Hulin, C.
    Ahlberg, L.
    de la Rubia, J.
    Abdulkadyrov, K.
    Ganguly, R.
    Diels, J.
    Dhawan, R.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 385 - 385
  • [5] PATIENT RESPONSE TO BORTEZOMIB IN RELAPSED/REFRACTORY MULTIPLE MYELOMA: INTERIM RESULTS FROM AN OBSERVATIONAL STUDY
    Zervas, K.
    Katodritou, E.
    Delforge, M.
    de Samblanx, H.
    Sargin, D.
    Hulin, C.
    Ahlberg, L.
    de la Rubia, J.
    Abdulkadyrov, K.
    Ganguly, R.
    Diels, J.
    Dhawan, R.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 614 - 614
  • [6] Efficacy of Bortezomib Plus Dexamethasone Versus Bortezomib Monotherapy In Patients with Relapsed/Refractory Multiple Myeloma: An Interim Report from an International Electronic Observational Study.
    Dimopoulos, Meletios A.
    De Samblanx, Hadewijch M.
    Roussou, Maria G.
    Zervas, Konstantinos
    Katodritou, Eirini
    Sargin, Deniz
    Hulin, Cyrille
    Ahlberg, Lucia
    De La Rubia, Javier
    Ganguly, Rita
    Diels, Joris K.
    van de Velde, Helgi
    Dhawan, Ravinder
    Spencer, Michael D.
    Delforge, Michel
    BLOOD, 2010, 116 (21) : 1247 - 1248
  • [7] EFFICACY OF BORTEZOMIB-BASED THERAPY IN RELAPSED/REFRACTORY MULTIPLE MYELOMA: Results FROM AN ELECTRONIC BORTEZOMIB OBSERVATIONAL STUDY (EVOBS) FOR PATIENT ENROLLED IN RUSSIAN FEDERATION
    Abdulkadyrov, K.
    Schmidt, A.
    Voloshin, S.
    Shuvaev, V.
    Kuvshinov, A.
    HAEMATOLOGICA, 2012, 97 : 598 - 599
  • [8] THE USE OF CARFILZOMIB AND BORTEZOMIB IN ROUTINE CLINICAL PRACTICE: RESULTS FROM PREAMBLE, AN ONGOING, OBSERVATIONAL COHORT STUDY IN MULTIPLE MYELOMA
    Durie, B.
    Cook, G.
    Goldschmidt, H.
    Kuter, D.
    Zyczynski, T.
    Popov, S.
    Gooriah, M.
    Davis, C.
    Vij, R.
    HAEMATOLOGICA, 2017, 102 : 520 - 520
  • [9] AN OBSERVATIONAL POST AUTHORIZATION STUDY ON THE USE OF BORTEZOMIB IN MULTIPLE MYELOMA PATIENTS IN THE NETHERLANDS: RESULTS OF AN INTERIM ANALYSIS
    Lokhorst, H.
    van der Heuls, C.
    Roerdink, H.
    De Weerdt, O.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 615 - 615
  • [10] An observational post authorization study on the use of bortezomib in multiple myeloma patients in the Netherlands: Results of an interim analysis
    Biesma, Douwe H.
    Lokhorst, Henk M.
    van der Hem, Klaas
    van der Heul, Cees
    BLOOD, 2007, 110 (11) : 276B - 276B
12345